Purple Biotech Ltd. Files 2024 Annual Report
Ticker: PPBT · Form: 20-F · Filed: Mar 10, 2025 · CIK: 1614744
Sentiment: neutral
Topics: annual-report, 20-f, biotech
TL;DR
Purple Biotech filed its 2024 20-F, check it out.
AI Summary
Purple Biotech Ltd. filed its annual report on Form 20-F for the fiscal year ended December 31, 2024. The company, formerly known as Kitov Pharma Ltd. and Kitov Pharmaceuticals Holdings Ltd., is incorporated in L3 and headquartered in Rehovot, Israel. The filing was made on March 10, 2025, under SEC file number 001-37643.
Why It Matters
This filing provides investors with a comprehensive overview of Purple Biotech's financial performance and business operations for the past fiscal year, crucial for assessing its current standing and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine annual report and does not contain immediate, high-impact news.
Key Numbers
- 20241231 — Fiscal Year End (The period covered by the annual report.)
- 20250310 — Filing Date (The date the annual report was submitted to the SEC.)
Key Players & Entities
- Purple Biotech Ltd. (company) — Filer of the 20-F
- Kitov Pharma Ltd. (company) — Former name of Purple Biotech Ltd.
- Kitov Pharmaceuticals Holdings Ltd. (company) — Former name of Purple Biotech Ltd.
- 001-37643 (dollar_amount) — SEC file number
FAQ
What is the primary business of Purple Biotech Ltd.?
Purple Biotech Ltd. is in the Pharmaceutical Preparations industry, SIC code 2834.
When was Purple Biotech Ltd. previously known by other names?
The company was formerly known as Kitov Pharma Ltd. (name change effective 20180125) and Kitov Pharmaceuticals Holdings Ltd. (name change effective 20140724).
Where is Purple Biotech Ltd. headquartered?
The company's business and mailing address is 4 Oppenheimer Street, Science Park, Rehovot, L3, 7670104.
What type of SEC filing is this document?
This document is an Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, specifically a Form 20-F.
What is the SEC file number for Purple Biotech Ltd.?
The SEC file number for Purple Biotech Ltd. is 001-37643.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on March 10, 2025 regarding PURPLE BIOTECH LTD. (PPBT).